Demant A/S

Demant A/S

WILYY
Demant A/SUS flagOther OTC
20.66
USD
- -
- -
8.71BMarket Cap
Demant A/S
WILYY
(Other OTC)

Recent

price

20.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
11.8
13.82
15.01
15.82
16.8
19.74
22.75
25.7
27.97
30.68
30.17
38.12
43.59
48.4
51.6
- -
Revenue per Share
1.69
2.06
2.02
2.27
2.38
2.66
2.77
3.42
3.66
3
2.34
5.35
4.61
4.02
5.49
- -
Basic EPS, GAAP
0.94
1.67
1.65
1.55
2
2.22
2.58
3.04
2.52
3.24
4.41
6.1
3.76
8.12
7.6
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
17.95
17.08
18.62
20.92
21.76
- -
Book Value per Share
1.18
2.15
2.48
2.55
2.84
0.97
0.38
1.05
-1.62
-1.91
-1.72
-4.97
-8.89
-9.42
-12.48
- -
Tangible Book Value per Share
584
582
570
566
556
540
528
513
498
487
480
470
452
446
434
- -
Basic Weighted Avg Shares
6,892
8,041
8,555
8,959
9,346
10,665
12,002
13,189
13,937
14,946
14,469
17,905
19,705
21,601
22,419
22,971
Sales/Revenue/Turnover
20.75
21.18
19.18
18.83
18.15
17.16
15.51
17.33
17.21
13.6
7.08
19.79
15.66
20.55
19.2
17.08
Operating Margin (%)
- -
233
267
292
294
325
404
404
446
959
1,048
1,065
1,176
1,293
1,435
1,519
Depreciation Expense
988
1,198
1,153
1,285
1,326
1,436
1,459
1,754
1,823
1,462
1,121
2,513
2,082
1,795
2,387
1,545
Net Income, GAAP
24.81
25.34
24.33
22.72
21.53
20.45
20.48
21.01
22.72
23.23
15.12
21.67
22.24
24.62
22.17
23.67
Effective Tax Rate (%)
14.34
14.9
13.48
14.34
14.19
13.46
12.16
13.3
13.08
9.78
7.75
14.04
10.57
8.31
10.65
6.73
Profit Margin (%)
193
529
-784
-887
-1,133
-321
-705
-363
-1,481
-1,930
-687
-3,087
-1,547
2,522
3,826
2,652
Working Capital
1,045
1,011
76
81
9
2,080
1,960
2,339
2,164
4,058
4,936
4,405
7,864
12,216
14,591
18,982
LT Debt
2,443
3,304
4,059
5,056
5,584
6,500
6,966
7,433
7,059
7,645
8,279
7,981
8,562
9,338
9,644
9,919
Total Equity
25.73
23.81
19.89
17.22
15.23
13.9
12.13
14.02
13.54
9.77
4.96
15.14
11.19
14.05
13.52
10.58
Return on Invested Capital (%)
47.61
50.46
47.77
43.88
39.8
33.47
27.92
32.07
29.4
18.36
8.72
13.96
10.4
9.26
11.79
8.5
Return on Capital (%)
1,688.89
2,065.52
1,987.93
2,234.78
2,326.32
2,587.39
2,727.1
3,340.95
3,574.51
2,953.54
25.9
30.22
25.33
20.22
25.41
32.54
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.43%
3.77%
2.85%
Free Cash Flow
15.84%
18.01%
-9.27%
Net Income, GAAP
7.36%
18.19%
-35.27%
Sales/Revenue/Turnover
8.18%
9.93%
2.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
21,601
2024
- -
- -
- -
- -
22,419
2025
- -
- -
- -
- -
22,971

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4.02
2024
- -
- -
- -
- -
5.49
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Demant A/S develops, manufactures and sells hearing healthcare products and equipment that help people with hearing loss connect and communicate with the world around them; core offerings span three business areas including Hearing Aids with brands such as Oticon, Bernafon and Sonic that provide advanced hearing devices incorporating AI-driven audio processing and chipsets; Hearing Care through the Audika Group delivering personalized retail hearing care services via a global network of clinics; and Diagnostics featuring equipment and services like audiometers, tympanometers and real-ear measurement systems from brands including Interacoustics, Maico and Grason-Stadler for hearing care professionals. The company operates in more than 30 countries, serves customers in over 130 markets primarily in Europe and North America, and employs more than 22,000 staff while generating annual revenue exceeding DKK 22 billion. Founded in 1904 and headquartered in Smørum, Denmark, Demant A/S lists on Nasdaq Copenhagen and is majority-owned by William Demant Invest A/S, the investment arm of the William Demant Foundation. Recent developments include the completion of its largest-ever acquisition of KIND Group on 1 December 2025 for EUR 700 million, adding approximately 650 hearing care clinics mainly in Germany, Switzerland, Austria, Luxembourg and Singapore to expand the Hearing Care footprint to over 4,500 clinics worldwide; a EUR 100 million loan from the Nordic Investment Bank in December 2024 to co-finance R&D investments in 2024 and 2025 focused on new hearing healthcare products, chipsets and AI algorithms; and an agreement signed to divest the Oticon Medical hearing implants business to Impilo for up to DKK 600 million, with closure expected by Q1 2026 to fully exit the implants segment.

Company News

APIChatGPT
  • Demant A/S (WILYY) Q4 2025 Earnings Call Transcript

  • Demant A/S (WILLF) Q2 2025 Earnings Call Transcript

  • Is Demant (WILYY) Stock Undervalued Right Now?

  • Demant A/S (WILLF) Q4 2024 Earnings Call Transcript

  • Best Momentum Stocks to Buy for March 26th

  • New Strong Buy Stocks for March 26th

  • New Strong Buy Stocks for March 19th

  • Best Momentum Stocks to Buy for March 11th

  • New Strong Buy Stocks for March 11th

  • Best Momentum Stocks to Buy for March 7th

  • New Strong Buy Stocks for March 7th

  • Best Momentum Stocks to Buy for March 4th

  • New Strong Buy Stocks for March 4th

  • Best Momentum Stocks to Buy for February 12th

  • Demant A/S (WILLF) Q4 2023 Earnings Call Transcript

  • Demant A/S (WILLF) Q2 2023 Earnings Call Transcript

  • Demant A/S (WILLF) Q3 2023 Earnings Call Transcript

  • The Scandinavian Shopping List In A Time Of Bargains